A new bioprocessing technique developed by a team of researchers could improve a range of therapies based on CAR-T cells.

Researchers investigated RA51C and uncovered over 3,000 harmful genetic changes that could increase cancer risk.

DFI therapy cost the UK’s NHS up to £962 million ($1.27 billion) each year. In the U.S., amputation cost alone is $1.38 ...

There is no general implemented and fully protective preventative treatment available for Group B Streptococcus.

Cancer cells can use lipids not just as fuel, but as a means to obscure inflammatory signals, enabling immune evasion.

An international collaboration of researchers in Europe and the U.S. has identified a critical immune factor for host defense against Staphylococcus aureus, which could offer a potential explanation ...

A Wyss Institute team has been selected to develop a broad-spectrum antimicrobial therapeutic under a contract from the DARPA ...

Using engineered mice, researchers developed monoclonal antibodies that were effective against infection with A. baumannii.

T cells refueled with extra mitochondria exhibited heightened antitumor activity and reduced signs of exhaustion in ...

The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...

Technologies for generating superphages and optimizing phage cocktails are poised to overcome antibiotic resistance and ...

Scientists from the Wistar Institute report that they have isolated and cloned fully human antibodies that can block specific ...